Matches in SemOpenAlex for { <https://semopenalex.org/work/W4367624392> ?p ?o ?g. }
- W4367624392 endingPage "146" @default.
- W4367624392 startingPage "134" @default.
- W4367624392 abstract "In recent decades, there has been an increase in the prevalence and medical and social burden of osteoarthritis (OA) and nonspecific back pain in all countries of the world. The First Multidisciplinary Bilateral Russia-Uzbekistan Expert Council presented innovations in the prognosing, personalized prevention and adjuvant therapy of degenerative-dystrophic diseases of the joints and spine, the evidence base for the effectiveness and safety of the use of drugs that modify the course of OA (Disease-modifying osteoarthritis drugs, DMOADs): chondroitin sulfate, glucosamine sulfate, undenatured type II collagen for adjuvant pharmaconutraceutical support – prevention and adjuvant therapy (treatment) of OA and nonspecific lumbosacral pain. The expert counsil resolution presents an optimized algorithm for the management, prevention and adjuvant therapy of OA and non-specific back pain, maintaining the function of healthy joints after intense physical activity with the inclusion of the drug Chondroguard solution for intra-articular and intramuscular administration (INN – chondroitin sulfate) and a new pharmaconutraceutical from the DMOADs group – TRIO trademark Chondroguard® (Chondroguard®TRIO)." @default.
- W4367624392 created "2023-05-02" @default.
- W4367624392 creator A5000253839 @default.
- W4367624392 creator A5000913174 @default.
- W4367624392 creator A5001296486 @default.
- W4367624392 creator A5006840361 @default.
- W4367624392 creator A5007756762 @default.
- W4367624392 creator A5010387683 @default.
- W4367624392 creator A5016927253 @default.
- W4367624392 creator A5019041776 @default.
- W4367624392 creator A5020896556 @default.
- W4367624392 creator A5021977160 @default.
- W4367624392 creator A5022195303 @default.
- W4367624392 creator A5025174599 @default.
- W4367624392 creator A5025942374 @default.
- W4367624392 creator A5026637146 @default.
- W4367624392 creator A5028317687 @default.
- W4367624392 creator A5033149870 @default.
- W4367624392 creator A5036516212 @default.
- W4367624392 creator A5045322569 @default.
- W4367624392 creator A5047319103 @default.
- W4367624392 creator A5054554481 @default.
- W4367624392 creator A5055184096 @default.
- W4367624392 creator A5057897616 @default.
- W4367624392 creator A5059216028 @default.
- W4367624392 creator A5060423215 @default.
- W4367624392 creator A5062748287 @default.
- W4367624392 creator A5065567527 @default.
- W4367624392 creator A5068287231 @default.
- W4367624392 creator A5070439223 @default.
- W4367624392 creator A5070594699 @default.
- W4367624392 creator A5071135587 @default.
- W4367624392 creator A5073451077 @default.
- W4367624392 creator A5076745765 @default.
- W4367624392 creator A5084061374 @default.
- W4367624392 creator A5086244162 @default.
- W4367624392 creator A5086450599 @default.
- W4367624392 date "2023-05-01" @default.
- W4367624392 modified "2023-10-12" @default.
- W4367624392 title "New pharmaconutraceutical Chondroguard®TRIO for the prevention of musculoskeletal diseases and nutritional support for patients with osteoarthritis and nonspecific back pain: an assessment of clinical options. Resolution of the Multidisciplinary Expert Council" @default.
- W4367624392 cites W1546820319 @default.
- W4367624392 cites W1909029774 @default.
- W4367624392 cites W1965665343 @default.
- W4367624392 cites W1971361997 @default.
- W4367624392 cites W1971447485 @default.
- W4367624392 cites W1979653063 @default.
- W4367624392 cites W2003528537 @default.
- W4367624392 cites W2005158748 @default.
- W4367624392 cites W2025445086 @default.
- W4367624392 cites W2069148797 @default.
- W4367624392 cites W2082306040 @default.
- W4367624392 cites W2083092719 @default.
- W4367624392 cites W2092983224 @default.
- W4367624392 cites W2097809720 @default.
- W4367624392 cites W2102308673 @default.
- W4367624392 cites W2102838907 @default.
- W4367624392 cites W2110535424 @default.
- W4367624392 cites W2115506640 @default.
- W4367624392 cites W2116272364 @default.
- W4367624392 cites W2123436542 @default.
- W4367624392 cites W2131049610 @default.
- W4367624392 cites W2146807038 @default.
- W4367624392 cites W2158093746 @default.
- W4367624392 cites W2161739351 @default.
- W4367624392 cites W2166080010 @default.
- W4367624392 cites W2274144009 @default.
- W4367624392 cites W2518491256 @default.
- W4367624392 cites W2588410069 @default.
- W4367624392 cites W2602269723 @default.
- W4367624392 cites W2745599707 @default.
- W4367624392 cites W2751795498 @default.
- W4367624392 cites W2751949480 @default.
- W4367624392 cites W2800106184 @default.
- W4367624392 cites W2887571592 @default.
- W4367624392 cites W2895799787 @default.
- W4367624392 cites W2905782592 @default.
- W4367624392 cites W2912654919 @default.
- W4367624392 cites W2914136481 @default.
- W4367624392 cites W2922415579 @default.
- W4367624392 cites W2981441878 @default.
- W4367624392 cites W3010721913 @default.
- W4367624392 cites W3011447062 @default.
- W4367624392 cites W3028355634 @default.
- W4367624392 cites W3101004220 @default.
- W4367624392 cites W3129050187 @default.
- W4367624392 cites W3135743173 @default.
- W4367624392 cites W3147053284 @default.
- W4367624392 cites W3152711804 @default.
- W4367624392 cites W3163330503 @default.
- W4367624392 cites W3180056648 @default.
- W4367624392 cites W4231421100 @default.
- W4367624392 cites W4246495358 @default.
- W4367624392 cites W4310725958 @default.
- W4367624392 cites W4311948682 @default.
- W4367624392 cites W4311951441 @default.
- W4367624392 cites W4318619377 @default.
- W4367624392 cites W4321370750 @default.
- W4367624392 doi "https://doi.org/10.14412/2074-2711-2023-2-134-146" @default.